NIH-funded research Fellowship grant

Understanding how neuroinflammation affects Alzheimer's and ALS

Official title: Dissecting neuroinflammatory mechanisms in a model of progressive TDP-43 pathology

Funded at Washington University · NIH-11030730 · Data updated 2026-11-12

This study is looking at how inflammation in the brain affects diseases like Alzheimer's and ALS, with the hope of finding new ways to help treat these conditions by understanding how certain proteins and genes are involved.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startFebruary 1, 2024
Project endJanuary 31, 2027
Funding year2025
Award (this year)$74,284
NIH project number5F32AG086044-02
Project IDNIH-11030730 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Alzheimer's Disease or Amyotrophic Lateral Sclerosis.

Less likely to help

Patients with neurodegenerative diseases not related to Alzheimer's or ALS may not benefit from this research.

What this research studies

This research investigates the role of neuroinflammation in neurodegenerative diseases like Alzheimer's Disease (AD) and Amyotrophic Lateral Sclerosis (ALS). It focuses on the mechanisms by which immune cells can harm healthy neurons, particularly through the dysregulation of a protein called TDP-43. By identifying specific genes and pathways involved in this process, the research aims to find new targets for therapies that could help manage or treat these conditions. Patients may benefit from insights that could lead to improved treatment options.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies that improve outcomes for patients with Alzheimer's and ALS.

How similar studies have gone: Previous research has shown promising results in targeting neuroinflammatory pathways in similar neurodegenerative conditions, suggesting that this approach could be effective.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: O'connor, James T — Washington University
  • Study coordinator: O'connor, James T

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.